Abstract
Lymphatic dissemination of tumor cells involves invasion into tumor-associated lymphatic vessels, seeding of metastases in the lymph nodes, and, ultimately, delivery into the blood circulation and to distant organs. Tumor lymphangiogenesis is induced by factors released by tumor or stromal cells, such as macrophages, and facilitates metastasis by providing pathways for cancer cell spread. Vascular endothelial growth factors VEGF-C and VEGF-D are the most specific lymphangiogenic factors that mediate signals for lymphatic endothelial cell growth and migration by binding to and activating VEGFR-3 receptors. Extensive preclinical data in mouse tumor models with specific inhibitors of lymphangiogenic signaling pathways provided the impetus for clinical trials of such agents in patients. In clinical practice, the presence of tumor cells in sentinel lymph nodes is an adverse prognostic factor for patients with solid tumors and constitutes a major consideration in tumor staging. Lymphovascular invasion, lymphatic vessel densities, and the expression of lymphangiogenic factors are also strongly correlated with poor prognosis. Although lymphatic and blood vascular endothelium share many molecular features, they are structurally and functionally distinct and play very different roles in tumors. Here, we discuss the distinct functions and significance of the lymphatic vascular system in cancer.
This is a preview of subscription content, log in via an institution.
References
Achen MG, Stacker SA (2012) Vascular endothelial growth factor-D: signaling mechanisms, biology, and clinical relevance. Growth Factors 30:283–296. https://doi.org/10.3109/08977194.2012.704917
Alitalo A, Detmar M (2011) Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 31:4499. https://doi.org/10.1038/onc.2011.602
Angeli V et al (2006) B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24:203–215. https://doi.org/10.1016/j.immuni.2006.01.003. S1074-7613(06)00102-6 [pii]
Aspelund A et al (2014) The Schlemm’s canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel. J Clin Invest 124:3975–3986. https://doi.org/10.1172/JCI75395
Aspelund A et al (2015) A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med 212:991–999. https://doi.org/10.1084/jem.20142290
Aukland K, Reed RK (1993) Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev 73:1–78. https://doi.org/10.1152/physrev.1993.73.1.1
Baluk P et al (2007) Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 204:2349–2362. https://doi.org/10.1084/jem.20062596
Banerji S et al (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144:789–801. https://doi.org/10.1083/jcb.144.4.789
Beasley NJ et al (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62:1315–1320
Bembenek AE et al (2007) Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg 245:858–863. https://doi.org/10.1097/01.sla.0000250428.46656.7e. 00000658-200706000-00004 [pii]
Ben-Baruch A (2008) Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 25:345–356. https://doi.org/10.1007/s10585-007-9097-3
Berk DA, Swartz MA, Leu AJ, Jain RK (1996) Transport in lymphatic capillaries. II. Microscopic velocity measurement with fluorescence photobleaching. Am J Phys 270:H330–H337. https://doi.org/10.1152/ajpheart.1996.270.1.H330
Brakenhielm E et al (2007) Modulating metastasis by a lymphangiogenic switch in prostate cancer. Int J Cancer 121:2153–2161. https://doi.org/10.1002/ijc.22900
Breiteneder-Geleff S et al (1997) Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 151:1141–1152
Breiteneder-Geleff S et al (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154:385–394. https://doi.org/10.1016/S0002-9440(10)65285-6
Breslin JW (2014) Mechanical forces and lymphatic transport. Microvasc Res 96:46–54. https://doi.org/10.1016/j.mvr.2014.07.013
Brown M et al (2018) Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. Science 359:1408–1411. https://doi.org/10.1126/science.aal3662
Burton JB et al (2008) Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res 68:7828–7837. https://doi.org/10.1158/0008-5472.CAN-08-1488. 68/19/7828 [pii]
Cabioglu N, Yazici MS, Arun B, Broglio KR, Hortobagyi GN, Price JE, Sahin A (2005) CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res 11:5686–5693. https://doi.org/10.1158/1078-0432.CCR-05-0014. 11/16/5686 [pii]
Cao R, Bjorndahl MA, Gallego MI, Chen S, Religa P, Hansen AJ, Cao Y (2006) Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood 107:3531–3536. https://doi.org/10.1182/blood-2005-06-2538
Cao R et al (2012) Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis. Proc Natl Acad Sci USA 109:15894–15899. https://doi.org/10.1073/pnas.1208324109
Carr I (1983) Lymphatic metastasis. Cancer Metastasis Rev 2:307–317
Carr I, Levy M, Orr K, Bruni J (1985) Lymph node metastasis and cell movement: ultrastructural studies on the rat 13762 mammary carcinoma and Walker carcinoma. Clin Exp Metastasis 3:125–139
Chen Z, Varney ML, Backora MW, Cowan K, Solheim JC, Talmadge JE, Singh RK (2005) Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival. Cancer Res 65:9004–9011. https://doi.org/10.1158/0008-5472.CAN-05-0885. 65/19/9004 [pii]
Cochran AJ et al (2000) The Augsburg consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 89:236–241
Comen E, Norton L, Massagué J (2011) Clinical implications of cancer self-seeding. Nat Rev Clin Oncol 8:369. https://doi.org/10.1038/nrclinonc.2011.64
Dadiani M, Kalchenko V, Yosepovich A, Margalit R, Hassid Y, Degani H, Seger D (2006) Real-time imaging of lymphogenic metastasis in orthotopic human breast cancer. Cancer Res 66:8037–8041. https://doi.org/10.1158/0008-5472.CAN-06-0728. 66/16/8037 [pii]
Dadras SS et al (2005) Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 18:1232–1242. https://doi.org/10.1038/modpathol.3800410
Das S, Skobe M (2008) Lymphatic vessel activation in cancer. Ann N Y Acad Sci 1131:235–241. https://doi.org/10.1196/annals.1413.021
Das S, Ladell DS, Podgrabinska S, Ponomarev V, Nagi C, Fallon JT, Skobe M (2010) Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases. Cancer Res 70:1814–1824. https://doi.org/10.1158/0008-5472.CAN-09-3675
Das S et al (2013) Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses. J Exp Med 210:1509–1528. https://doi.org/10.1084/jem.20111627
Davydova N et al (2016) Differential receptor binding and regulatory mechanisms for the lymphangiogenic growth factors vascular endothelial growth factor (VEGF)-C and -D. J Biol Chem 291:27265–27278. https://doi.org/10.1074/jbc.M116.736801
Dewar DJ, Newell B, Green MA, Topping AP, Powell BW, Cook MG (2004) The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 22:3345–3349. https://doi.org/10.1200/JCO.2004.12.177. 22/16/3345 [pii]
Dicken BJ et al (2006) Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg 243:64–73
Dixon JB (2010) Mechanisms of chylomicron uptake into lacteals. Ann N Y Acad Sci 1207(Suppl 1):E52–E57. https://doi.org/10.1111/j.1749-6632.2010.05716.x
Escobedo N, Oliver G (2016) Lymphangiogenesis: origin, specification, and cell fate determination. Annu Rev Cell Dev Biol 32:677–691. https://doi.org/10.1146/annurev-cellbio-111315-124944
Falchook GS et al (2014) A first-in-human phase I study of VGX-100, a selective anti-VEGF-C antibody, alone and in combination with bevacizumab in patients with advanced solid tumors. J Clin Oncol 32:2524–2524. https://doi.org/10.1200/jco.2014.32.15_suppl.2524
Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453–458. https://doi.org/10.1038/nrc1098
Furudoi A, Tanaka S, Haruma K, Kitadai Y, Yoshihara M, Chayama K, Shimamoto F (2002) Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology 62:157–166. ocl62157 [pii]
Gerli R, Ibba L, Fruschelli C (1990) A fibrillar elastic apparatus around human lymph capillaries. Anat Embryol 181:281–286
Gibot L, Galbraith T, Kloos B, Das S, Lacroix DA, Auger FA, Skobe M (2016) Cell-based approach for 3D reconstruction of lymphatic capillaries in vitro reveals distinct functions of HGF and VEGF-C in lymphangiogenesis. Biomaterials 78:129–139. https://doi.org/10.1016/j.biomaterials.2015.11.027
Goldsmith HS, Bailey HD, Callahan EL, Beattie EJ Jr (1967) Pulmonary lymphangitic metastases from breast carcinoma. Arch Surg 94:483–488
Greaves M, Maley CC (2012) Clonal evolution in cancer. Nature 481:306–313. https://doi.org/10.1038/nature10762
Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127:679–695. https://doi.org/10.1016/j.cell.2006.11.001
Haessler U, Pisano M, Wu M, Swartz MA (2011) Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Proc Natl Acad Sci USA 108:5614–5619. https://doi.org/10.1073/pnas.1014920108
Haiko P et al (2008) Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol Cell Biol 28:4843–4850. https://doi.org/10.1128/MCB.02214-07
Harrell MI, Iritani BM, Ruddell A (2007) Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 170:774–786. https://doi.org/10.2353/ajpath.2007.060761. 170/2/774 [pii]
Hartgrink HH et al (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069–2077. https://doi.org/10.1200/JCO.2004.08.026
Hayashi K et al (2007) Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res 67:8223–8228. https://doi.org/10.1158/0008-5472.CAN-07-1237. 67/17/8223 [pii]
He Y et al (2005) Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65:4739–4746. https://doi.org/10.1158/0008-5472.CAN-04-4576. 65/11/4739 [pii]
Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201:1089–1099. https://doi.org/10.1084/jem.20041896
Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109:1010–1017. https://doi.org/10.1182/blood-2006-05-021758
Hoda SA, Hoda RS, Merlin S, Shamonki J, Rivera M (2006) Issues relating to lymphovascular invasion in breast carcinoma. Adv Anat Pathol 13:308–315. https://doi.org/10.1097/01.pap.0000213048.69564.26
Hoshida T et al (2006) Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 66:8065–8075. https://doi.org/10.1158/0008-5472.CAN-06-1392
Houshmand P, Zlotnik A (2003) Therapeutic applications in the chemokine superfamily. Curr Opin Chem Biol 7:457–460. S1367593103000863 [pii]
Hunter KW, Amin R, Deasy S, Ha N-H, Wakefield L (2018) Genetic insights into the morass of metastatic heterogeneity. Nat Rev Cancer 18:211–223. https://doi.org/10.1038/nrc.2017.126
Ikomi F, Schmid-Schonbein GW (1996) Lymph pump mechanics in the rabbit hind leg. Am J Phys 271:H173–H183. https://doi.org/10.1152/ajpheart.1996.271.1.H173
Ishigami S et al (2007) Prognostic value of CCR7 expression in gastric cancer. Hepato-Gastroenterology 54:1025–1028
Jackson DG (2004) Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS 112:526–538. https://doi.org/10.1111/j.1600-0463.2004.apm11207-0811.x
Janower ML, Blennerhassett JB (1971) Lymphangitic spread of metastatic cancer to the lung. A radiologic-pathologic classification. Radiology 101:267–273
Jeltsch M et al (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423–1425
Johnson LA, Prevo R, Clasper S, Jackson DG (2007) Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J Biol Chem 282:33671–33680. https://doi.org/10.1074/jbc.M702889200
Jones D, Pereira ER, Padera TP (2018) Growth and immune evasion of lymph node metastasis. Front Oncol 8:36. https://doi.org/10.3389/fonc.2018.00036
Joukov V et al (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:1751
Joukov V et al (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16:3898–3911. https://doi.org/10.1093/emboj/16.13.3898
Kaipainen A et al (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566–3570. https://doi.org/10.1073/pnas.92.8.3566
Kajiya K, Sawane M, Huggenberger R, Detmar M (2009) Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis. J Invest Dermatol 129:1292–1298. https://doi.org/10.1038/jid.2008.351
Karaman S, Detmar M (2014) Mechanisms of lymphatic metastasis. J Clin Invest 124:922–928. https://doi.org/10.1172/JCI71606
Karaman S, Leppanen VM, Alitalo K (2018) Vascular endothelial growth factor signaling in development and disease. Development 145. https://doi.org/10.1242/dev.151019
Karnezis T et al (2012) VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 21:181–195. https://doi.org/10.1016/j.ccr.2011.12.026
Kataru RP et al (2009) Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113:5650–5659. https://doi.org/10.1182/blood-2008-09-176776
Kawakami M, Yanai Y, Hata F, Hirata K (2005) Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model. Surg Today 35:131–138. https://doi.org/10.1007/s00595-004-2896-0
Kerjaschki D et al (2004) Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 15:603–612
Kerjaschki D et al (2011) Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J Clin Invest 121:2000–2012. https://doi.org/10.1172/JCI44751
Kim H, Kataru RP, Koh GY (2014) Inflammation-associated lymphangiogenesis: a double-edged sword? J Clin Invest 124:936–942. https://doi.org/10.1172/JCI71607
Krishnan J et al (2003) Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res 63:713–722
Kyzas PA, Geleff S, Batistatou A, Agnantis NJ, Stefanou D (2005) Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 206:170–177. https://doi.org/10.1002/path.1776
Lambert AW, Pattabiraman DR, Weinberg RA (2017) Emerging biological principles of metastasis. Cell 168:670–691. https://doi.org/10.1016/j.cell.2016.11.037
Leak LV (1971) Studies on the permeability of lymphatic capillaries. J Cell Biol 50:300–323. https://doi.org/10.1083/jcb.50.2.300
Leak LV, Burke JF (1966) Fine structure of the lymphatic capillary and the adjoining connective tissue area. Am J Anat 118:785–809. https://doi.org/10.1002/aja.1001180308
Lee AH, Pinder SE, Macmillan RD, Mitchell M, Ellis IO, Elston CW, Blamey RW (2006) Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer 42:357–362. https://doi.org/10.1016/j.ejca.2005.10.021
Lim B, Woodward WA, Wang X, Reuben JM, Ueno NT (2018a) Inflammatory breast cancer biology: the tumour microenvironment is key. Nat Rev Cancer 18:485–499. https://doi.org/10.1038/s41568-018-0010-y
Lim HY et al (2018b) Hyaluronan receptor LYVE-1-expressing macrophages maintain arterial tone through hyaluronan-mediated regulation of smooth muscle cell collagen. Immunity 49:1191. https://doi.org/10.1016/j.immuni.2018.12.009
Lin J et al (2005) Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Res 65:6901–6909. https://doi.org/10.1158/0008-5472.CAN-05-0408. 65/15/6901 [pii]
Lotan Y et al (2005) Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23:6533–6539. https://doi.org/10.1200/JCO.2005.05.516
Louveau A et al (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523:337–341. https://doi.org/10.1038/nature14432
Ma Q et al (2018) Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread. Sci Adv 4:eaat4758–eaat4758. https://doi.org/10.1126/sciadv.aat4758
Makinen T, Norrmen C, Petrova TV (2007) Molecular mechanisms of lymphatic vascular development. Cell Mol Life Sci 64:1915–1929. https://doi.org/10.1007/s00018-007-7040-z
Mandriota SJ et al (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20:672–682. https://doi.org/10.1093/emboj/20.4.672
Marusyk A, Tabassum DP, Altrock PM, Almendro V, Michor F, Polyak K (2014) Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature 514:54–58. https://doi.org/10.1038/nature13556
Mashino K et al (2002) Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 62:2937–2941
Mauri C, Wang G, Schulte-Merker S (2018) From fish embryos to human patients: lymphangiogenesis in development and disease. Curr Opin Immunol 53:167–172. https://doi.org/10.1016/j.coi.2018.05.003
May M, Kaufmann O, Hammermann F, Loy V, Siegsmund M (2007) Prognostic impact of lymphovascular invasion in radical prostatectomy specimens. BJU Int 99:539–544. https://doi.org/10.1111/j.1464-410X.2006.06650.x
McAllister SS, Weinberg RA (2014) The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol 16:717–727. https://doi.org/10.1038/ncb3015
Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG (2007) Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 96:1092–1100. https://doi.org/10.1038/sj.bjc.6603678
Moore JE Jr, Bertram CD (2018) Lymphatic system flows. Annu Rev Fluid Mech 50:459–482. https://doi.org/10.1146/annurev-fluid-122316-045259
Morton DL et al (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399
Morton DL et al (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355:1307–1317. https://doi.org/10.1056/NEJMoa060992. 355/13/1307 [pii]
Mouta Carreira C, Nasser SM, di Tomaso E, Padera TP, Boucher Y, Tomarev SI, Jain RK (2001) LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 61:8079–8084
Muller A et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56. https://doi.org/10.1038/35065016
Nakamura Y et al (2005) Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res Treat 91:125–132. https://doi.org/10.1007/s10549-004-5783-x
Naxerova K et al (2017) Origins of lymphatic and distant metastases in human colorectal cancer. Science (New York, NY) 357:55–60. https://doi.org/10.1126/science.aai8515
Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194:23–28
O-charoenrat P, Rhys-Evans P, Eccles SA (2001) Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 92(3):556–568. PubMed PMID:11505400. https://doi.org/10.1002/1097-0142(20010801)92:3<556::AID-CNCR1355>3.0.CO;2-Q
Ohtani O, Ohtani Y (2008) Structure and function of rat lymph nodes. Arch Histol Cytol 71:69–76. JST.JSTAGE/aohc/71.69 [pii]
Olmeda D et al (2017) Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine. Nature 546:676–680. https://doi.org/10.1038/nature22977
Park DY et al (2014) Lymphatic regulator PROX1 determines Schlemm’s canal integrity and identity. J Clin Invest 124:3960–3974. https://doi.org/10.1172/JCI75392
Pereira ER et al (2018) Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 359:1403–1407. https://doi.org/10.1126/science.aal3622
Persaud K et al (2004) Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C. J Cell Sci. https://doi.org/10.1242/jcs.01138
Petrova TV, Koh GY (2018) Organ-specific lymphatic vasculature: from development to pathophysiology. J Exp Med 215:35–49. https://doi.org/10.1084/jem.20171868
Podgrabinska S, Skobe M (2014) Role of lymphatic vasculature in regional and distant metastases. Microvasc Res 95:46–52. https://doi.org/10.1016/j.mvr.2014.07.004
Podgrabinska S, Braun P, Velasco P, Kloos B, Pepper MS, Skobe M (2002) Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci USA 99:16069–16074. https://doi.org/10.1073/pnas.242401399242401399. [pii]
Pytowski B et al (2005) Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 97:14–21. https://doi.org/10.1093/jnci/dji003
Rayter Z (ed) (2003) Medical therapy of breast cancer. Cambridge University Press, Cambridge, UK
Roberts N et al (2006) Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res 66:2650–2657. https://doi.org/10.1158/0008-5472.CAN-05-1843. 66/5/2650 [pii]
Rockson SG (2001) Lymphedema. Am J Med 110:288–295
Rockson SG, Keeley V, Kilbreath S, Szuba A, Towers A (2019) Cancer-associated secondary lymphoedema. Nat Rev Dis Primers 5:22. https://doi.org/10.1038/s41572-019-0072-5
Ruddell A, Kelly-Spratt KS, Furuya M, Parghi SS, Kemp CJ (2008) p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis. Oncogene 27:3145–3155. https://doi.org/10.1038/sj.onc.1210973
Saharinen P, Eklund L, Alitalo K (2017a) Therapeutic targeting of the angiopoietin-TIE pathway. Nat Rev Drug Discov 16:635–661. https://doi.org/10.1038/nrd.2016.278
Saharinen P, Leppanen VM, Alitalo K (2017b) SnapShot: angiopoietins and their functions. Cell 171:724–724 e721. https://doi.org/10.1016/j.cell.2017.10.009
Saif MW et al (2016) Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer. Cancer Chemother Pharmacol 78:815–824. https://doi.org/10.1007/s00280-016-3134-3
Sáinz-Jaspeado M, Claesson-Welsh L (2018) Cytokines regulating lymphangiogenesis. Curr Opin Immunol 53:58–63. https://doi.org/10.1016/j.coi.2018.04.003
Scallan JP, Zawieja SD, Castorena-Gonzalez JA, Davis MJ (2016) Lymphatic pumping: mechanics, mechanisms and malfunction. J Physiol 594:5749–5768. https://doi.org/10.1113/JP272088
Schmid-Schonbein GW (1990a) Mechanisms causing initial lymphatics to expand and compress to promote lymph flow. Arch Histol Cytol 53(Suppl):107–114
Schmid-Schonbein GW (1990b) Microlymphatics and lymph flow. Physiol Rev 70:987–1028. https://doi.org/10.1152/physrev.1990.70.4.987
Schmid-Schonbein GW (2003) The second valve system in lymphatics. Lymphat Res Biol 1:25–29. https://doi.org/10.1089/15396850360495664; discussion 29–31
Schumann K et al (2010) Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 32:703–713. https://doi.org/10.1016/j.immuni.2010.04.017. S1074-7613(10)00166-4 [pii]
Shields JD et al (2004) Lymphatic density and metastatic spread in human malignant melanoma. Br J Cancer 90:693–700. https://doi.org/10.1038/sj.bjc.6601571
Shields JD et al (2007a) Chemokine-mediated migration of melanoma cells towards lymphatics – a mechanism contributing to metastasis. Oncogene 26:2997–3005. https://doi.org/10.1038/sj.onc.1210114
Shields JD, Fleury ME, Yong C, Tomei AA, Randolph GJ, Swartz MA (2007b) Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling Cancer. Cell 11:526–538. https://doi.org/10.1016/j.ccr.2007.04.020
Skobe M, Detmar M (2000) Structure, function, and molecular control of the skin lymphatic system. J Investig Dermatol Symp Proc 5:14–19. https://doi.org/10.1046/j.1087-0024.2000.00001.x
Skobe M et al (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192–198. https://doi.org/10.1038/84643
Sleeman J, Schmid A, Thiele W (2009) Tumor lymphatics. Semin Cancer Biol 19:285–297. https://doi.org/10.1016/j.semcancer.2009.05.005
Srinivasan RS et al (2007) Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev 21:2422–2432. https://doi.org/10.1101/gad.1588407
Stacker SA et al (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186–191. https://doi.org/10.1038/84635
Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, Achen MG (2014) Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer 14:159–172. https://doi.org/10.1038/nrc3677
Straume O, Akslen LA (1996) Independent prognostic importance of vascular invasion in nodular melanomas. Cancer 78:1211–1219. https://doi.org/10.1002/(SICI)1097-0142(19960915)78:6<1211::AID-CNCR7>3.0.CO;2-C. [pii] 1381002/(SICI)1097-0142(19960915)78:6<1211::AID-CNCR7>3.0.CO;2-C
Swartz MA (2001) The physiology of the lymphatic system. Adv Drug Deliv Rev 50:3–20
Swartz MA, Berk DA, Jain RK (1996) Transport in lymphatic capillaries. I Macroscopic measurements using residence time distribution theory. Am J Phys 270:H324–H329. https://doi.org/10.1152/ajpheart.1996.270.1.H324
Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS (2004) CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 10:2351–2358
Tal O et al (2011) DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J Exp Med 208:2141–2153. https://doi.org/10.1084/jem.20102392
Tammela T, Alitalo K (2010) Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140:460–476. https://doi.org/10.1016/j.cell.2010.01.045
Thomas A, Lenox R (2008) Pulmonary lymphangitic carcinomatosis as a primary manifestation of colon cancer in a young adult. CMAJ 179:338–340. https://doi.org/10.1503/cmaj.080142. 179/4/338 [pii]
Tomashefski JF, Dail DH (2008) Dail and Hammar’s pulmonary pathology, 3rd edn. Springer, New York
Trapnell DH (1964) Radiological Appearances of Lymphangitis Carcinomatosa of the Lung. Thorax 19:251–260
Uchida D, Onoue T, Tomizuka Y, Begum NM, Miwa Y, Yoshida H, Sato M (2007) Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma. Mol Cancer Res 5:685–694. https://doi.org/10.1158/1541-7786.MCR-06-0368
Ulvmar MH, Makinen T (2016) Heterogeneity in the lymphatic vascular system and its origin. Cardiovasc Res 111:310–321. https://doi.org/10.1093/cvr/cvw175
Van den Eynden GG et al (2006) Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer. Br J Cancer 95:1362–1366. https://doi.org/10.1038/sj.bjc.6603443
Van den Eynden GG et al (2007) Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clin Cancer Res 13:5391–5397. https://doi.org/10.1158/1078-0432.CCR-07-1230
Van der Auwera I et al (2006) First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 95:1611–1625. https://doi.org/10.1038/sj.bjc.6603445
Vona G et al (2000) Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 156:57–63. https://doi.org/10.1016/S0002-9440(10)64706-2
Wang J et al (2012) Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature. Mol Biol Rep 39:11153–11165. https://doi.org/10.1007/s11033-012-2024-y
Weber M et al (2013) Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science 339:328–332. https://doi.org/10.1126/science.1228456
Welsh JD, Kahn ML, Sweet DT (2016) Lymphovenous hemostasis and the role of platelets in regulating lymphatic flow and lymphatic vessel maturation. Blood 128:1169–1173. https://doi.org/10.1182/blood-2016-04-636415
Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G (2006) Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9:261–272. https://doi.org/10.1016/j.ccr.2006.03.010
Wigle JT, Oliver G (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98:769–778
Wiig H, Swartz MA (2012) Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev 92:1005–1060. https://doi.org/10.1152/physrev.00037.2011
Wiley HE, Gonzalez EB, Maki W, Wu MT, Hwang ST (2001) Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93:1638–1643
Wu CW et al (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7:309–315. https://doi.org/10.1016/S1470-2045(06)70623-4
Yang Y, Oliver G (2014) Development of the mammalian lymphatic vasculature. J Clin Invest 124:888–897. https://doi.org/10.1172/JCI71609
Yokoyama Y et al (2003) Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer 88:237–244. https://doi.org/10.1038/sj.bjc.6600701
Zawieja DC (2009) Contractile physiology of lymphatics. Lymphat Res Biol 7:87–96. https://doi.org/10.1089/lrb.2009.0007
Zhang S, Zhang D, Gong M, Wen L, Liao C, Zou L (2017) High lymphatic vessel density and presence of lymphovascular invasion both predict poor prognosis in breast cancer. BMC Cancer 17:335. https://doi.org/10.1186/s12885-017-3338-x
Zheng W, Aspelund A, Alitalo K (2014) Lymphangiogenic factors, mechanisms, and applications. J Clin Invest 124:878–887. https://doi.org/10.1172/JCI71603
Zlotnik A, Burkhardt AM, Homey B (2011) Homeostatic chemokine receptors and organ-specific metastasis. Nat Rev Immunol 11:597. https://doi.org/10.1038/nri3049
Acknowledgments
We thank Anita Rogic and Aaron Sun for the editorial help and Ruben Fernandez-Rodriguez for the illustrations. We apologize to all those whose work is not cited due to the space constraints. This work was supported by the NCI/NIH award R01CA172637 (M.S.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Skobe, M., Pytowski, B. (2019). Significance and Molecular Regulation of Lymphangiogenesis in Cancer. In: Marmé, D. (eds) Tumor Angiogenesis. Springer, Cham. https://doi.org/10.1007/978-3-319-31215-6_51-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-31215-6_51-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31215-6
Online ISBN: 978-3-319-31215-6
eBook Packages: Springer Reference MedicineReference Module Medicine